OR WAIT null SECS
September 21, 2026
Article
FDA expands marstacimab approval to children and patients with inhibitors, backed by new BASIS trial data.
September 20, 2026
Stay updated with the latest healthcare breakthroughs, including Bayer's finerenone expanding to type 1 diabetes-associated CKD.
September 16, 2026
New ASH guidelines recommend higher ferritin thresholds to improve the diagnosis of iron deficiency across key populations.
September 01, 2026
A pediatric hematologist unpacks why sickle cell disease burden, treatment access, and pain outcomes differ across sub-Saharan Africa, other LMICs, and HICs.
Stacey Rifkin-Zenenberg, DO, marks Sickle Cell Disease Awareness Month with insight on gene therapy vs. transplant.
August 27, 2026
A phase 2 study found the EAP regimen achieved optimal stem cell mobilization in most patients with multiple myeloma or lymphoma, with low plerixafor need.
August 25, 2026
Nipocalimab-aahu (IMAAVY) is now approved for wAIHA, based on Phase 2/3 ENERGY trial data showing durable hemoglobin response.
August 20, 2026
Video
Genetic variants tied to CAR T toxicity and expansion could guide how researchers screen healthy donors for allogeneic CAR T products.
August 13, 2026
Germline STXBP2 variants may predict severe CAR T cell toxicity, Mark B. Leick, MD, and colleagues find
August 12, 2026
New research links germline genetic variants to CAR T cell toxicity risk and expansion in lymphoma patients treated with axi-cel.